[For which patients with cardiac decompensation is prevention of thromboembolism advisable?].
D000925:Anticoagulants / Q000627:therapeutic use*; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications / Q000503:physiopathology; D006322:Heart Aneurysm / Q000150:complications / Q000503:physiopathology; D006333:Heart Failure / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D018579:Patient Selection; D011655:Pulmonary Embolism / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D013923:Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants
In quali pazienti con scompenso cardiaco è consigliabile una profilassi delle tromboembolie?